Citadel Advisors’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Citadel Advisors's ADRX Position: Q3 2026 in Review
Citadel Advisors opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 340,987 shares worth $6.8M. The stake represents ﹤0.01% of the portfolio and ranks #4311 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Citadel Advisors held 340,987 shares of ADARx Pharmaceuticals worth $6.8M as of Q3 2026.
- ADARx Pharmaceuticals was a new Citadel Advisors position in Q3 2026.
- ADARx Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #4311 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.